Tuomas Ropponen

Papers

Total Citations

H-Index

About

Tuomas Ropponen is a researcher at the forefront of applying artificial intelligence to clinical oncology, with a primary focus on prostate cancer diagnostics and prognostics. His most cited work, "AI Model for Prostate Biopsies Predicts Cancer Survival" (2022, 19 citations), introduces a novel AI algorithm designed to detect and grade prostate cancer directly from biopsy slides. This study, based on over 4,200 scanned slides from nearly 900 biopsy sessions at HUS Helsinki University Hospital, demonstrates how deep learning can not only identify malignancy but also predict patient survival outcomes. By integrating AI into routine pathology workflows, Ropponen’s contributions help bridge the gap between computational methods and clinical decision-making, offering the potential for more precise, automated risk stratification. His work is particularly notable for its use of real-world clinical data, ensuring translational relevance. As AI continues to reshape precision medicine, Ropponen’s research stands out for its direct impact on improving diagnostic accuracy and prognostic insight in prostate cancer care.